KLF13 and non-small cell lung carcinoma: We found that treatment with miR‐3126‐5p inhibitor‐Exos restrained miR‐3126‐5p expression (Figure 6H) and raised KLF13 expression (Figure 6I) in NSCLC cells, and these results were reversed in the miR‐3126‐5p mimics‐Exos group (Figure 6H,I).